PMC:7247521 / 12240-12339
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 206 | 53-61 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 207 | 70-91 | Disease | denotes | robustness of disease | MESH:D003141 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T157 | 19-23 | CHEBI:23888;CHEBI:23888 | denotes | drug |
| T158 | 53-61 | SP_7 | denotes | COVID-19 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T39 | 53-61 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T63 | 19-23 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T76 | 0-99 | Sentence | denotes | 2.8 Validation of drug positioning for QFPD against COVID-19 via the robustness of disease network |